FDA use of the black box warning: time for reevaluation as a safety tool.
Liang
Bryan A
BA
D000932:Antiemetics / Q000009:adverse effects*; D004329:Droperidol / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
D000932:Antiemetics; D004329:Droperidol